We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+7.64%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$2.5B
AUM Growth
+$144M
Cap. Flow
+$16.9M
Cap. Flow %
0.68%
Top 10 Hldgs %
23.95%
Holding
453
New
26
Increased
85
Reduced
124
Closed
20

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$23M
2
NVAX icon
Novavax
NVAX
+$18.4M
3
IQ icon
iQIYI
IQ
+$17.4M
4
CBOE icon
Cboe Global Markets
CBOE
+$17M
5
NFLX icon
Netflix
NFLX
+$16.8M

Top Sells

Rank Stock Value
1
SRPT icon
Sarepta Therapeutics
SRPT
+$27.7M
2
ROKU icon
Roku
ROKU
+$20.6M
3
SPG icon
Simon Property Group
SPG
+$16.5M
4
NIO icon
NIO
NIO
+$15.7M
5
MRNA icon
Moderna
MRNA
+$13.5M

Sector Composition

Rank Sector Weight
1 Consumer Staples 21.66%
2 Healthcare 21.01%
3 Consumer Discretionary 11.38%
4 Communication Services 10.4%
5 Materials 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILD icon
1
Gilead Sciences
GILD
$188B
$72.3M 2.89%
1,050,145
-27,705
-3% -$1.85M
CLX icon
2
Clorox
CLX
$11.4B
$63.9M 2.56%
355,204
+18,347
+5% +$3.35M
GIS icon
3
General Mills
GIS
$21B
$63.1M 2.53%
1,036,385
+104,657
+11% +$6.47M
DPZ icon
4
Domino's
DPZ
$11.5B
$61.4M 2.46%
131,528
-23,246
-15% -$9.86M
K
5
DELISTED
Kellanova
K
$58.1M 2.33%
962,217
-8,685
-0.9% -$527K
GEN icon
6
Gen Digital
GEN
$18.8B
$57.9M 2.32%
2,127,932
-418,657
-16% -$10.4M
CAG icon
7
Conagra Brands
CAG
$7.5B
$57.3M 2.29%
1,574,121
+20,976
+1% +$785K
EXR icon
8
Extra Space Storage
EXR
$29.8B
$56.5M 2.26%
345,091
-11,653
-3% -$1.75M
SJM icon
9
J.M. Smucker
SJM
$13.7B
$56M 2.24%
432,188
-12,204
-3% -$1.62M
CPB icon
10
Campbell Soup
CPB
$6.6B
$51.8M 2.07%
1,136,032
+101,161
+10% +$4.87M
ABMD
11
DELISTED
Abiomed Inc
ABMD
$50.1M 2%
160,395
-1,904
-1% -$584K
NEM icon
12
Newmont
NEM
$137B
$49.9M 2%
787,586
-119,437
-13% -$8M
LLY icon
13
Eli Lilly
LLY
$1.03T
$49.9M 2%
217,352
+114,334
+111% +$23M
BIIB icon
14
Biogen
BIIB
$33.2B
$48.9M 1.96%
141,244
-25,856
-15% -$7.83M
TDOC icon
15
Teladoc Health
TDOC
$1.18B
$45.9M 1.84%
276,178
+52,056
+23% +$8.43M
ED icon
16
Consolidated Edison
ED
$40.2B
$43.8M 1.75%
610,416
+4,413
+0.7% +$339K
PTON icon
17
Peloton Interactive
PTON
$2.36B
$42.9M 1.72%
345,829
-6,628
-2% -$706K
HRL icon
18
Hormel Foods
HRL
$11.9B
$41.8M 1.67%
876,014
+201,723
+30% +$9.61M
SNAP icon
19
Snap
SNAP
$9.64B
$41.7M 1.67%
612,390
-117,404
-16% -$7.05M
FNV icon
20
Franco-Nevada
FNV
$52.1B
$41.7M 1.67%
286,746
-57,329
-17% -$8.3M
LUMN icon
21
Lumen
LUMN
$7.13B
$38.4M 1.54%
2,823,396
+1,116,492
+65% +$15.4M
PCG icon
22
PG&E
PCG
$30.7B
$38.3M 1.53%
3,766,862
+553,630
+17% +$5.94M
MRNA icon
23
Moderna
MRNA
$59.4B
$38M 1.52%
161,677
-75,355
-32% -$13.5M
NET icon
24
Cloudflare
NET
$101B
$37.8M 1.51%
357,401
-95,245
-21% -$7.88M
REG icon
25
Regency Centers
REG
$13.9B
$36.9M 1.48%
575,873
+14,934
+3% +$945K

Similar funds

TOBAM's Q2 2021 Portfolio in Review

As of Q2 2021, TOBAM held 453 positions worth $2.5B, up 6.1% from $2.35B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

TOBAM's Q2 2021 filing shows 26 new, 85 increased, 124 reduced and 20 closed positions. Its largest new stake was GFL Environmental: 313,947 shares worth $10M. The largest sale was Sarepta Therapeutics, an estimated $27.7M.

By sector, the portfolio is most concentrated in Consumer Staples at 22% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • TOBAM's largest Q2 2021 buy was GFL Environmental: 313,947 shares worth $10M.
  • TOBAM added most to Eli Lilly in Q2 2021, an estimated $23M increase.
  • TOBAM's biggest Q2 2021 reduction was Roku, cutting an estimated $20.6M.
  • TOBAM fully exited Sarepta Therapeutics in Q2 2021, selling an estimated $27.7M.
  • TOBAM's ten largest holdings make up 24% of its $2.5B portfolio in Q2 2021.
  • TOBAM opened 26 new positions and closed 20 in Q2 2021.
  • TOBAM's portfolio value rose 6.1% quarter-over-quarter to $2.5B.

Based on TOBAM's 13F filing for Q2 2021, filed 11 Aug 2021.